Compare REPL & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REPL | NX |
|---|---|---|
| Founded | 2015 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 721.7M | 599.2M |
| IPO Year | 2018 | N/A |
| Metric | REPL | NX |
|---|---|---|
| Price | $10.17 | $16.45 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 906.3K |
| Earning Date | 11-06-2025 | 12-11-2025 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,837,641,000.00 |
| Revenue This Year | N/A | $2.52 |
| Revenue Next Year | N/A | $3.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $2.68 | $11.04 |
| 52 Week High | $14.80 | $29.67 |
| Indicator | REPL | NX |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 76.88 |
| Support Level | $9.35 | $13.18 |
| Resistance Level | $11.09 | $14.11 |
| Average True Range (ATR) | 0.60 | 0.84 |
| MACD | -0.08 | 0.42 |
| Stochastic Oscillator | 53.32 | 55.16 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.